breakthrough therapy

Video: breakthrough therapy

      Breakthrough therapy GudangMovies21 Rebahinxxi LK21

      Breakthrough therapy is a United States Food and Drug Administration designation that expedites drug development that was created by Congress under Section 902 of the 9 July 2012 Food and Drug Administration Safety and Innovation Act. The FDA's "breakthrough therapy" designation is not intended to imply that a drug is actually a "breakthrough" or that there is high-quality evidence of treatment efficacy for a particular condition; rather, it allows the FDA to grant priority review to drug candidates if preliminary clinical trials indicate that the therapy may offer substantial treatment advantages over existing options for patients with serious or life-threatening diseases. The FDA has other mechanisms for expediting the review and approval process for promising drugs, including fast track designation, accelerated approval, and priority review.


      Requirements


      A breakthrough therapy designation can be assigned to a drug if "it is a drug which is intended alone or in combination with one or more other drugs to treat a serious or life threatening disease or condition" and if the preliminary clinical evidence indicates that the drug may demonstrate substantial improvement over existing therapies on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development."
      Requests are reviewed by the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation and Research (CBER). CDER receives approximately 100 requests per year for breakthrough designation. Historically, about one third were approved. CBER receives 15–30 requests per year. Sponsors must apply for breakthrough status separately for each indication they intend to label the drug for.
      Breakthrough designation applications are submitted as an amendment to the IND applications, usually prior to end of Phase II meeting.


      Incentives


      Drugs that have been granted breakthrough status are given priority review. The FDA works with the sponsor of the drug application to expedite the approval process. This expedited process can include rolling reviews, smaller clinical trials, and alternative trial designs.


      Issues


      Critics have said that the name is misleading and provides companies that obtain a breakthrough designation for a drug candidate with a marketing advantage that may be undeserved. The FDA acknowledges that the name "breakthrough therapy" may be misleading. It was never meant to imply that these drugs are actually "breakthroughs," and it does not ensure that they will provide clinical benefit, but still critics complain that they are based on preliminary evidence, including changes in surrogate markers such as laboratory measurements, that often don't reflect "meaningful clinical benefit."
      The FDA guidance states: "Not all products designated as breakthrough therapies ultimately will be shown to have the substantial improvement over available therapies suggested by the preliminary clinical evidence at the time of designation. If the designation is no longer supported by subsequent data, FDA may rescind the designation."


      See also


      List of drugs granted breakthrough therapy designation
      FDA Fast Track Development Program
      Priority review (FDA)
      Orphan drug


      References




      External links


      Media related to Breakthrough therapy at Wikimedia Commons

    Kata Kunci Pencarian: breakthrough therapy

    breakthrough therapybreakthrough therapy centerbreakthrough therapy servicesbreakthrough therapy st georgebreakthrough therapy designation listbreakthrough therapy solutionsbreakthrough therapy services reviewsbreakthrough therapy daviebreakthrough therapy meaningbreakthrough therapy miami Search Results

    breakthrough therapy

    Daftar Isi

    Breakthrough Therapy | FDA

    Breakthrough Therapy designation is a process designed to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates...

    Frequently Asked Questions: Breakthrough Therapies | FDA

    Breakthrough therapy designation is intended to expedite the development and review of drugs for serious or life-threatening conditions.

    Breakthrough therapy - Wikipedia

    Breakthrough therapy is a United States Food and Drug Administration designation that expedites drug development that was created by Congress under Section 902 of the 9 July 2012 Food …

    What Is an FDA Breakthrough Therapy Designation?

    Nov 4, 2024 · Learn how the FDA’s Breakthrough Therapy Designation accelerates the development of promising treatments for serious conditions, offering biotech companies an …

    Breakthrough Therapy Approvals - FDA

    Jan 13, 2025 · The CDER Breakthrough Therapy (BT) Approvals reports contain a list of approvals for breakthrough therapy designated drugs. New reports will be published quarterly …

    Petosemtamab granted Breakthrough Therapy designation by the …

    6 days ago · This marks the second BTD for petosemtamab in HNSCCUTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 18, 2025 (GLOBE NEWSWIRE) -- Merus N.V. …

    Breakthrough-Therapy Designation — An FDA Perspective

    Apr 11, 2018 · The authors provide a perspective on the rationale and goals of the designation of “breakthrough therapy” by the Food and Drug Administration.

    Special FDA designations for drug development: orphan, fast …

    We conducted a keyword search to identify studies analyzing the impact of the FDA's special designations (orphan, fast track, accelerated approval, priority review, and breakthrough …

    Expediting Drug Development — The FDA's New “Breakthrough Therapy ...

    Nov 14, 2013 · Once a drug is designated as a breakthrough therapy, the FDA commits to working particularly closely with the drug sponsor to devise the most efficient pathway for generating …

    Breakthru Physical Therapy | 14 Convenient New Jersey Locations

    With 14 locations in 5 New Jersey counties, Breakthru Physical Therapy + Fitness could not be more convenient! Our skilled physical therapists match the proper techniques with each …